Imed 2013

1,879 views
1,828 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,879
On SlideShare
0
From Embeds
0
Number of Embeds
6
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Imed 2013

  1. 1. International Meeting on Emerging Diseases and Surveillance Vienna, Austria • February 15 –18, 2013 Co-sponsored by ProMED-mail, the Program for Monitoring Emerging Diseases EcoHealth Alliance European Centre for Disease Prevention and Control ( ECDC ) European Society of Clinical Microbiology and Infectious Diseases ( ESCMID) Food and Agriculture Organization of the United Nations ( FAO) HealthMap Skoll Global Threats Fund (SGTF) World Organisation for Animal Health (OIE ) Organized by the International Society for Infectious Diseases FINAL PROGRAM
  2. 2. 16th International Congresson Infectious Diseases Cape Town • SouTh afriCa april 2~5, 2014 organized by the international Society for infectious Diseases in collaboration with the federation of infectious Diseases Societies of Southern africa
  3. 3. 2013 IMED International Meeting on E m e r g i n g D i s e a s e s and Surveillance Co-sponsored by ProMED-mail, the Program for Monitoring Emerging Diseases EcoHealth Alliance European Centre for Disease Prevention and Control ( ECDC )European Society of Clinical Microbiology and Infectious Diseases ( ESCMID) Food and Agriculture Organization of the United Nations ( FAO) HealthMap Skoll Global Threats Fund (SGTF) World Organisation for Animal Health (OIE ) Organized by the International Society for Infectious Diseases FINAL PROGRAM
  4. 4. Table of Contents International Meeting on Emerging Diseases and Surveillance 2 013 Welcome. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Committees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 General Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Floorplans | Hilton Vienna . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Program-at-a-Glance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 . Scientific Program. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Friday, February 15, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Saturday, February 16, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Sunday, February 17, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Monday, February 18, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Poster Presentations I • Saturday, February 16, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 Poster Presentations II • Sunday, February 17, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 Abstracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 Friday, February 15, 2013 Session 01: Science and Sensationalism, Emerging Infections and Emergency!. . . . . . . . . . . . . . . . . . . . 37 Session 02: Ecology, Biodiversity, Climate and Emerging Infectious Disease . . . . . . . . . . . . . . . . . . . . . . 37 Session 03: Emerging Infectious Diseases and the Hajj. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 Saturday, February 16, 2013 Session 04: Emerging Disease Prevention. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 Session 05: Oral Presentations: One Health in Action . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 Session 06: Emerging Fungal Diseases and Species Extinction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 Session 07: Of Bats and Men: Nipah and Other Infections. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45 . Session 08: Oral Presentations: ‘Contagion’: Contemporary Viral Pathogens. . . . . . . . . . . . . . . . . . . . 46 . Session 09: Emerging Disease Mysteries. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48 Session 10: Vectorborne Diseases in Humans and Animals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50 Sunday, February 17, 2013 Session 11: Neglected Zoonotic Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51 Session 12: Oral Presentations: Infection, Detection, and Protection: Adventures in Epidemiology. . 52 . Session 13: Global Approach to the Control of Foot and Mouth Disease. . . . . . . . . . . . . . . . . . . . . . 56 . Session 14: Cutting Edge Diagnostics for the Detection of Novel and Neglected Diseases. . . . . . . . 56 Session 15: Updates from ProMED (Panel Discussion). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57 Session 16: Disease Surveillance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57 Session 17: Oral Presentations: Hot Topics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58 Monday, February 18, 2013 Session 18: Economics of Emerging Infectious Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62 Session 19: Diseases Without Borders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62 Session 20: Big Data, Industry and Disease Surveillance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64 Poster Presentations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 Saturday, February 16, 2013 Session 21: Poster Presentations I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 Antimicrobial Resistance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 Bioterrorism and Biological Warfare. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76 Climate Change and Ecological Factors in Disease Emergence. . . . . . . . . . . . . . . . . . . . . . . . . . 77 Diseases at the Interface of Humans, Wildlife and Other Animals. . . . . . . . . . . . . . . . . . . . . . . 80 . Diseases of Animals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91 Foodborne and Waterborne Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96 Infections of Public Health Significance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103 Infections Related to Travel and Migration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121 Innovations in Diagnostic Tests for Emerging Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124 New Pathogen Discovery. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126 Sunday, February 17, 2013 Session 22: Poster Presentations II. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127 Influenza and Other Respiratory Infections. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127 New Approaches to Outbreak Surveillance and Monitoring. . . . . . . . . . . . . . . . . . . . . . . . . . . 136 New, Emerging and Neglected Zoonotic Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148 Outbreak Modeling. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160 Outbreak Response and Control. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161 . Public Communication of Outbreaks and Emerging Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . 168 Sociopolitical Factors in Disease Emergence. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168 Vaccines and Emergence of Vaccine Preventable Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170 Vectorborne Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174 Index of Authors and Co-Authors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191 ii IMED 2013
  5. 5. Welcome International Meeting on Emerging Diseases and Surveillance 2 013 Welcome to the great city of Vienna and the fourth International Meeting on Emerging Diseases and Surveillance, IMED 2013. Now established as a fixture for those whose work deals with threats from infectious agents, IMED 2013 will once again bring leading scientists, clinicians and policy makers together to present new knowledge and breakthroughs and discuss how to discover, detect, understand, prevent and respond to outbreaks of emerging pathogens. Since the last IMED, newly emerged diseases and outbreaks of familiar ones have continued to challenge us and keep us vigilant. While the influenza pandemic that began in 2009 has quieted, an early and severe flu season has occurred in the Northern hemisphere and eruptions of H5N1 highly pathogenic avian influenza in poultry, wild birds and humans continue to occur. A new strain of H3N2 has transmitted from pigs to humans and, at least occasionally, from person to person.. A novel coronavirus has caused severe human disease in several countries and the newly discovered Schmallenberg virus, has emerged in livestock in Northern Europe. Diseases at the human-wildlife interface ranging from rabies to plague to Nipah virus continue to draw our attention. Growing resistance by pathogens to all types of therapeutic agents raises fundamental obstacles to our ability to respond to outbreaks and pandemics. The threat of intentional use of biological agents for nefarious purposes remains as real as ever. Since its inception, IMED has been a summit that unifies our approach to pathogens in the broadest ecological context. Drawing together human and veterinary health specialists, IMED serves as a true One Health forum where those working in diverse specialties and diverse regions can meet, discuss, present and challenge one another with findings and new ideas. This year, over 700 abstracts were submitted, a record number. A selection of the best among these will be presented in two poster sessions and four oral sessions. A meeting of this scope could not occur without the help of many, and I particularly want to thank our co-sponsors for making IMED possible: EcoHealth Alliance, the European Centers for Disease Control and Prevention (ECDC), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), HealthMap, the Skoll Global Threats Fund (SGTF) and the World Organisation for Animal Health (OIE). We also acknowledge the generous technical con- tribution of the Food and Agriculture Organization of the United Nations (FAO) and the sup- port from the Vienna Convention Bureau, the Mayor of Vienna and Austrian Airlines. While pathogens emerge and mutate, our methodology for detection, surveillance, prevention, control, and treatment also continue to evolve. New approaches to the uses of social media and data mining, novel laboratory methods, rapid point-of-care diagnostics, risk communication, political and societal responses to outbreaks have all seen innovation and change that will be explored at IMED 2013. Thank you for your participation. Sincerely, Larry MADOFF Chair, Scientific Program Committee Editor, ProMED-mail, International Society for Infectious Diseases Boston, USA 1 IMED 2013
  6. 6. Committees International Meeting on Emerging Diseases and Surveillance 2 013 Scientific Program Committee Larry Madoff, Boston, MA, USA – Chair Jacques Acar, Paris, France Yin Myo Aye, Bangkok, Thailand Daniel Beltrán-Alcrudo, Rome, Italy Timothy Brewer, Montreal, Canada John Brownstein, Boston, MA, USA Ilaria Capua, Padova, Italy Giuseppe Cornaglia, Verona, Italy Sidi Coulibaly, Ouagadougou, Burkina Faso Benson Estambale, Nairobi, Kenya David Fisman, Toronto, Canada Antoine Flahault, Paris, France Johann Giesecke, Stockholm, Sweden David Heymann, London, United Kingdom Jim Hughes, Atlanta, GA, USA Damien Joly, Nanaimo, BC, Canada William Karesh, New York, NY, USA Keith Klugman, Atlanta, GA, USA Daniel Lucey, Washington, DC, USA Nina Marano, Nairobi, Kenya Abla Mawadeku, Ottawa, Canada Kazuaki Miyagishima, Paris, France Norbert Nowotny, Vienna, Austria & Muscat, Oman Philip Polgreen, Iowa City, IA, USA Co-Sponsors Marjorie Pollack, New York, NY, USA Natalia Psenichnaya, Rostov-on-Don, Russia Arnon Shimshony, Jerusalem, Israel Mark Smolinski, San Francisco, CA, USA Eric Summers, Boston, MA., USA Jaime Torres, Caracas, Venezuela Jack Woodall, Rio de Janeiro, Brazil Co-Sponsors * ProMED-mail, the Program for Monitoring Emerging Diseases EcoHealth Alliance European Centre for Disease Prevention and Control (ECDC) European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Food and Agriculture Organization of the United Nations ( FAO)* HealthMap Skoll Global Threats Fund (SGTF) World Organisation for Animal Health (OIE) * With a technical contribution from the Food and Agriculture Organization of the United Nations. 2 IMED 2013
  7. 7. Committees International Meeting on Emerging Diseases and Surveillance 2 013 Cooperating Organizations Austrian Agency for Health and Food Safety (AGES) Austrian Federal Ministry of Health Austrian Society for Infectious Diseases (ÖEGIT) Austrian Society of Hygiene, Microbiology and Preventive Medicine (ÖGHMP) Austrian Society of Tropical Medicine and Parasitology (ÖGTP) International Society for Infectious Diseases (ISID) International Society for Disease Surveillance (ISDS) University of Veterinary Medicine Vienna – (Vetmeduni Vienna) Contributors Austrian Airlines City of Vienna EcoHealth Alliance International Society for Infectious Diseases (ISID) Vienna Hilton Am Stadtpark Vienna Convention Bureau Exhibitors Amplex BioSystems European Centre for Disease Prevention and Control (ECDC) Food and Agriculture Organization of the United Nations (FAO) International Society of Travel Medicine (ISTM) World Organisation for Animal Health (OIE) R-Biopharm We invite you to visit the Exibits in the Pre-Function Area on the Ground Level. Organizer & Conference Office International Society for Infectious Diseases 9 Babcock Street, Unit 3, Brookline, MA 02446, USA phone: (617) 277-0551 • fax: (617) 278-9113 email: info@isid.org web: http://www.isid.org • http://imed.isid.org Exhibition Office Media Plan Freyung 6 1010 Vienna, Austria Phone: (+43 1) 536 63 0 Fax: (+43 1) 535 60 16 Email: mp@media.co.at 3 IMED 2013
  8. 8. G eneral I nformation International Meeting on Emerging Diseases and Surveillance 2 013 Opening Hours of the Registration and Information Desk Friday, February 15, 2013 11:00 – 19:00hrs Saturday, February 16, 2013 08:00 – 18:00hrs Sunday, February 17, 2013 08:00 – 18:00hrs Monday, February 18, 2013 08:00 – 12:00hrs Congress Venue Hilton Vienna • Am Stadtpark • 1030 Vienna • Tel: +43 1 717 000 • http://www.hilton.com Registration Fees Participants: EUR 495.00 Students: EUR 275.00 Social Program The Welcome Reception will be held on Friday, February 15 from 17:30 to 19:00hrs at the Hilton Hotel Vienna on the Gallery (Upper Level). The Mayor’s Reception will take place on Sunday, February 17 at 20:00hrs at the Vienna City Hall (entrance: Lichtenfelsgasse, 1010 Vienna). An invitation card is needed to gain access to this reception.The price is EUR 20,00 per person. Onsite registration is subject to availability. For both functions business attire is appropriate. Badges Please wear your name badge at all times during the conference in order to gain access to the scientific program and all conference functions. Internet Access The Hilton provides free internet access in the main hotel lobby. WiFi access in the sleeping rooms and conference area is available for a special conference fee if you present your IMED name badge. Tickets can be purchased from the reception desk on the ground level (EUR 10 for 24 hours). CME The International Meeting on Emerging Diseases and Surveillance –IMED 2013 is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. The International Meeting on Emerging Diseases and Surveillance –IMED 2013 is designated for a maximum of, or up to 17 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits.™ Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme. Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. RACE (Veterinary CE) The American Association of Veterinary State Boards RACE committee has reviewed and ap- proved IMED 2013 as meeting the Standards adopted by the AAVSB, (maximum CME for one veterinarian: 16.5). This course meets the requirements for hours of continuing education in jurisdictions which recognize AAVSB RACE approval; however, participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery. All CME forms are included in the congress bag. Please complete and return forms to the ISID after the conference is over as indicated on the form. 4 IMED 2013
  9. 9. G eneral I nformation International Meeting on Emerging Diseases and Surveillance 2 013 Poster Presentations Poster presentations will be held on Saturday, February 16 and Sunday, February 17 from 11.45 to 13.15hrs. During this period all presenters must be available for discussion at their posters. Set-up for Poster Presentations I: Saturday, February 16 from 08:00 to 10:30hrs Removal: Saturday, February 16 from 16:30 to 18:00hrs Set-up for Poster Presentations II: Sunday, February 17 from 08:00 to 10:30hrs Removal: Sunday, February 17 from 16:30 to 18:00hrs Poster Areas (Upper Level) Saturday, February 16, 2013 / Poster Presentations I 11:45–13:15 Room Bruckner/Mahler/Brahms / Upper Level: Abstract Number Topic 21.001 – 21.032 Antimicrobial resistance 21.033 – 21.034 Bioterrorism and biological warfare 21.035 – 21.045 Climate change and ecological factors in disease emergence 21.046 – 21.079 Diseases at the interface of humans, wildlife and other animals 21.080 – 21.095 Diseases of animals 21.096 – 21.114 Foodborne and waterborne diseases 21.115 – 21.127 Infections of public health significance Klimt Ballroom I / Upper Level: Abstract Number Topic 21.128 – 21.169 Infections of public health significance (continued) 21.170 – 21.180 Infections related to travel and migration 21.181 – 21.184 Innovations in diagnostic tests for emerging diseases 21.185 – 21.187 New pathogen discovery Sunday, February 17, 2013 / Poster Presentations II 11:45–13:15 Room Bruckner/Mahler/Brahms / Upper Level: Abstract Number Topic 22..001 – 22.027 Influenza and other respiratory infections 22..028 – 22.060 New approaches to outbreak surveillance and monitoring 22..061 – 22.093 New, emerging, and neglected zoonotic diseases 22..094 – 22.097 Outbreak modeling 22..098 – 22.116 Outbreak response and control 22.117 – 22.118 Public communication of outbreaks and emerging diseases 22.119 – 22.125 Sociopolitical factors in disease emergence Klimt Ballroom I / Upper Level: Abstract Number Topic 22.126 – 22.138 Vaccines and emergence of vaccine preventable diseases 22.139 – 22.185 Vectorborne diseases 5 IMED 2013
  10. 10. Floorplans • H ilton A m Stadtpark Vienna International Meeting on Emerging Diseases and Surveillance 2 013 GROUND LEVEL Park Congress Pre-Function REGISTRATION Area PLENARY EXHIBITION HALL COFFEE FIRST LEVEL ProMED-mail Meeting (Mon.) POSTERS BREAK-OUT SESSIONS Brahms Klimt Klimt Ballroom Ballroom 1 2&3 Gallery Gallery POSTERS Mahler Bruckner Gallery COFFEE Schonberg 6 IMED 2013
  11. 11. Program - at- a-G lance International Meeting on Emerging Diseases and Surveillance 2 013 Time Friday, February 15, 2013 Room 11:00–19:00 Registration and Information Desk Foyer/Park Congress/Ground Level 14:00–14:20 Welcome & Opening Park Congress/Ground Level 14:20–15:00 Session I: Plenary Lecture: Science and Sensationalism, Park Congress/Ground Level Emerging Infections and Emergency! 15:00–16:30 Session 2: Plenary Lecture: Ecology, Biodiversity, Climate and Park Congress/Ground Level Emerging Infectious Disease 16:30–17:15 Session 3: Plenary Lecture: Emerging Infectious Diseases Park Congress/Ground Level and the Hajj 17:30–19:00 Welcome: Cocktail Reception Gallery/Upper Level Time Saturday, February 16, 2013 Room 08:30–10:30 2 Break-out Sessions: Session 4: Emerging Disease Prevention Park Congress/Ground Level Session 5: Oral Presentations: One Health in Action Klimt Ballroom 2&3/Upper Level 10:30–11:00 Coffee Break Ground Level and Upper Level 11:00–11:45 Session 6: Plenary Lecture: Emerging Fungal Diseases and Park Congress/Ground Level Species Extinction 11:45–13:15 Poster Presentations I (Session 21) Bruckner/Mahler/Brahms/Upper Level and Klimt Ballroom1/Upper Level 14:30–16:00 2 Break-out Sessions: Session 7: Of Bats and Men: Nipah and Other Infections Park Congress/Ground Level Session 8: Oral Presentations: ‘Contagion’: Contemporary Klimt Ballroom 2&3/Upper Level Viral Pathogens 16:00–16:30 Coffee Break Ground Level and Upper Level 16:30–18:00 2 Break-out Sessions: Session 9: Emerging Disease Mysteries Park Congress/Ground Level Session 10: Vectorborne Diseases in Humans and Animals Klimt Ballroom 2&3/Upper Level Time Sunday, February 17, 2013 Room 08:30–10:30 2 Break-out Sessions: Session 11: Neglected Zoonotic Diseases Park Congress/Ground Level Session 12: Oral Presentations: Infection, Detection, and Klimt Ballroom 2&3/Upper Level Protection: Adventures in Epidemiology 10:30–11:00 Coffee Break Ground Level and Upper Level 11:00–11:45 Session 13: Plenary Lecture: Global Approach to the Park Congress/Ground Level Control of Foot and Mouth Disease 11:45–13:15 Poster Presentations II (Session 22) Bruckner/Mahler/Brahms/Upper Level and Klimt Ballroom1/Upper Level 14:30–16:00 2 Break-out Sessions: Session 14: Cutting Edge Diagnostics for the Detection of Park Congress/Ground Level Novel and Neglected Diseases Session 15: Updates from ProMED (Panel Discussion) Klimt Ballroom 2&3/Upper Level 16:00–16:30 Coffee Break Ground Level and Upper Level 16:30–18:00 2 Break-out Sessions: Session 16: Disease Surveillance Park Congress/Ground Level Session 17: Oral Presentations: Hot Topics Klimt Ballroom 2&3/Upper Level 20:00–22:00 Mayor’s Reception Vienna City Hall (Entrance: Liechtenfelsgasse) Time Monday, February 18, 2013 Room 08:30–10:30 2 Break-out Sessions: Session 18: Economics of Emerging Infectious Diseases Park Congress/Ground Level Session 19: Diseases without Borders Klimt Ballroom 2&3/Upper Level 10:30–11:00 Coffee Break Ground Level and Upper Level 11:00–11:45 Session 20: Plenary Lecture: Big Data, Industry and Park Congress/Ground Level Disease SurveillanceThe program is subject to changes! 7 IMED 2013
  12. 12. S cientific Program FRIDAY • FEBRUARY 15, 2013 International Meeting on Emerging Diseases and Surveillance 2 013 Opening Session Session 02 Room: Park Congress 14:00–14:20 Plenar y Lectures Ground Level Friday, February 15, 2013 Ecology, Biodiversity, Climate andFebruary 15, 2013 Welcome by the President of the Emerging Infectious Diseases International Society for Infectious Diseases (ISID) Co-Chairs: William Karesh, USA Keith Klugman Juan Lubroth, Italy Atlanta, GA (USA) Room: Park Congress 15:00–16:30 • Welcome to Vienna Ground Level Friday, February 15, 2013FRIDAY Norbert Nowotny 02.001 Different views of looking at biodiversity Vienna (Austria) and health W. Karesh Official Opening of the Conference New York, NY (USA) Pamela Rendl-Wagner, Director General, Public Health, Austria 02.002 Concerns of the biodiversity community for Vienna (Austria) integrating health D. Coates Welcome to IMED 2013 Montreal (Canada) Larry Madoff 02.003 Climate change, biodiversity loss, desertification Boston, MA (USA) and human health - the WHO Perspective D. Campbell-Lendrum Geneva (Switzerland) 02.004 Wildlife trade and emerging diseases- Impacts on biodiversity and health K. Smith New York, NY (USA) Co-sponsored by EcoHealth Alliance Session 03 Plenar y Lecture Emerging Infectious Diseases and the Hajj Chair: Marjorie Pollack, USA Session 01 Room: Park Congress 16:30–17:15 Ground Level Friday, February 15, 2013 Plenar y Lecture Science and Sensationalism, Emerging 03.001 Emerging infectious diseases and the Hajj Z. Memish Infections and Emergency! Riyadh (Saudi Arabia) Chair: Keith Klugman, USA Room: Park Congress 14:20–15:00 Welcome Cocktail Reception Ground Level Friday, February 15, 2013 Gallery 17:30–19:00 01.001 Science and sensationalism, emerging infections Upper Level Friday, February 15, 2013 and emergency! A. Schuchat Atlanta, GA (USA) 8 IMED 2013
  13. 13. S cientific Program SATURDAY • FEBRUARY 16, 2013 International Meeting on Emerging Diseases and Surveillance 2 013 05.004 Monitoring of influenza virus in pigs andSession 04 humans in SwitzerlandEmerging Disease Prevention M. Engels1, Y. Thomas2, E. Fuchsini3, R. Born4,Co-Chairs: Julio Pinto, Italy S. Bruhn4 Nina Marano, Kenya 1 Zurich (Switzerland), 2Geneva (Switzerland), 3 Sempbach (Switzerland), 4Berne (Switzerland)Room: Park Congress 8:30–10:30 05.005 Coxiella burnetti seroprevalence and risk factorsGround Level Saturday, February 16, 2013 in dairy cattle farmers and farm residents in the04.001 Introduction to FAOs role in emerging disease Netherlands prevention J. Hautvast1, N. Schotten1, B. Schimmer 2, J. Lubroth P. Schneeberger 3, P. Vellema4, Y. van Duynhoven2 Rome (Italy) 1 Nijmegen (Netherlands), 2Bilthoven (Netherlands), 3Den Bosch (Netherlands),04.002 Strengthening laboratory networks and strategies 4 Deventer (Netherlands) to meet the challenges of emerging and transboundary animal diseases (TADs) threats 05.006 High colonization rate of farmers, their relatives F. Claes and employees at pig farms with emerging Clostridium difficile PCR ribotype 078 SATURDAY Rome (Italy)04.003 Innovation to fill the gaps in disease surveillance: E. Keessen1, M. Hensgens2, M. Bos1, W. Dohmen1, Participatory surveillance, applied technologies J. Wagenaar3, D. Heederik1, E. Kuijper2, L. Lipman1 for better understanding and reporting 1 Utrecht (Netherlands), 2Leiden (Netherlands), 3 Netherland (Netherlands) • J. Pinto February 16, 2013 Rome (Italy) 05.007 West Nile Disease in Italy: Animal surveillance04.004 Dealing with the biocomplexity of emerging activities as an early warning system for the infectious diseases (EIDs): An ecosystem health prevention and control of the infection in humans approach R. Bruno, D. Di Sabatino, A. Carvelli, F. De D. Beltrán-Alcrudo Massis, P. Calistri Rome (Italy) Teramo (Italy)With a technical contribution from the Food and Agriculture 05.008 Sylvatic origin and geographic spread ofOrganization of the United Nations. St. Louis encephalitis virus A. Kopp1, T. Gillespie2, D. Hobelsberger3, A. Estrada4, I. Eckerle1, M. Mueller1,Session 05 L. Podsiadlowski5, F. Leendertz3,Oral Presentations C. Drosten1, S. Junglen1 1 Bonn (Germany), 2Atlanta, GA (USA), 3BerlinOne Health in Action (Germany), 4Mexico City (Mexico),Co-Chairs: Tim Brewer, USA 5 Bonn (Germany) Natalia Pshenichnaya, Russian Federation 05.009 Considerable relation with foot-and-mouthRoom: Klimt Ballroom 2&3 8:30–10:30 disease (FMD) infection in Japan, 2010; TrafficUpper Level Saturday, February 16, 2013 roads and pig farming area R. Ushijima05.001 Evaluating long-term behavior change resulting Miyazaki (Japan) from an intervention to prevent Nipah virus transmission from bats to humans in Bangladesh 05.010 West Nile Virus in Canada: 2002–2012 R. Sultana, U. K. Mondal, J. Abedin, M. J. Hossain, H. Zheng, A. S. Yasseen, P. A. Buck, F. Welsh, M. A. Y. Sharker, N. A. Rimi, E. Gurley, N. Nahar, M. Raizenne S. P. Luby Ottawa, ON (Canada) Dhaka (Bangladesh) 05.011 Zoonotic diseases monitored by Brazil National05.002 Characterizing high risk disease transmission IHR Focal Point from March 2006 to June 2012 interfaces in the global pursuit of emerging M. É. Santos, S. Lopes Dias, E. T. Masuda, zoonotic diseases P. Pereira Vasconcelos de Oliveira, G. S. Dimech C. K. Johnson1, T. W. Smiley1, T. Goldstein1, Brasilia (Brazil) W. Karesh2, D. Joly3, P. Daszak2, J. Mazet1 1 Davis, CA (USA), 2New York, NY (USA), 3 Nanaimo, BC (Canada)05.003 Rabies control in Bali: A “one health” approach E. Russell, F. Abson 9 London (United Kingdom) IMED 2013
  14. 14. S cientific Program SATURDAY • FEBRUARY 16, 2013 International Meeting on Emerging Diseases and Surveillance 2 013 Coffee Break Session 08 Ground Level 10:30–11:00 Oral Presentations and Upper Level Saturday, February 16, 2013 ‘Contagion’: Contemporary Viral Pathogens Session 06 Co-Chairs: Sidi Coulibaly, Burkina Faso Stuart Handysides, United Kingdom Plenar y Lecture Room: Klimt Ballroom 2&3 14:30–16:00 Emerging Fungal Threats to Animal, Upper Level Saturday, February 16, 2013 Plant and Ecosystem Health Chair: John Brownstein, USA 08.001 Hepatitis E virus antigen detection: An early diagnostic marker  Room: Park Congress 11:00–11:45 R. Ratho, M. Majumdar, M. P. Singh, Y. Chawla Ground Level Saturday, February 16, 2013 Chandigarh (India) 06.001 Emerging fungal threats to animal, plant 08.002 Evolution of H3N2 influenza viruses fromFebruary 16, 2013 and ecosystem health the Philippines M. Fisher B. C. Torres1, Y. C. F. Su2, M. S. H. Chua2, H. Guo2, London (United Kingdom) A. K. Cruz1, D. C. Klinzing1, G. J. D. Smith2, F. F. Natividad1 1 Quezon City (Philippines), 2Singapore Poster Presentations I (Session 21) (Singapore) • 08.003 Influence of the viral membrane, inherited fromSATURDAY Saturday, February 16, 2013 11:45–13:15 different host species, on survival of influenza A Bruckner/Mahler/Brahms - Upper Level viruses in water and Klimt Ballroom 1 - Upper Level S. Shigematsu, A. Dublineau, L. I. O. Sawoo, Sessions 21.001–21.187 (see pages 65–126) I. Leclercq, J.-C. Manuguerra Paris (France) 08.004 Investigation of deaths due by Influenza A(H1N1) Session 07 pdm09 in Southern Brazil, July-August, 2012 Of Bats and Men: Nipah and R. Soletti1, W. Oliveira1, F. Costa1, F. de Paula1, R. Moreira1, L. Garay2, M. Bercini2, E. M. Macario1, Other Infections C. N. Igansi1, W. Araújo1 Co-Chairs: Daniel Lucey, USA 1 Brasília (Brazil), 2Porto Alegre(Brazil) Damien Joly, Canada 08.005 Enhancing the specificity of surveillance case Room: Park Congress 14:30–16:00 detection of Monkeypox in Democratic Republic Ground Level Saturday, February 16, 2013 of Congo (DRC). L. U. Osadebe1, A. McCollum1, R. S. Lushima2, 07.001 Understanding the ecology of Nipah virus in E. Pukuta2, S. Karhemere2, J. Kabamba2, B. Nguete2, frugivorous bats in Bangladesh I. Damon1, J. J. Muyembe2, M. Reynolds1 J. H. Epstein 1 Atlanta, GA (USA), 2Kinshasa (Congo, New York, NY (USA) Democratic Republic of) 07.002 From bats to human-to-human transmission 08.006 First autochthonous outbreak of dengue in the of Nipah virus in Bangladesh island of Madeira, October 2012: A challenge for H. S. Sazzad the European Union Region Dhaka (Bangladesh) P.Vasconcelos1, H. Zeller2, C. Abreu Santos1, 07.003 “One Health” Surveillance for Nipah virus B. Sudre2, J. Gomes Dias2, J. Jansa2, A. C. Silva3, in Thailand A. Nunes3, A. Leça1, K. Mansinho1 S. Wacharapluesadee 1 Lisbon (Portugal), 2Stockholm (Sweden), Bangkok (Thailand) 3 Funchal (Portugal) 10 IMED 2013
  15. 15. S cientific Program SATURDAY • FEBRUARY 16, 2013 International Meeting on Emerging Diseases and Surveillance 2 01308.007 Dengue fever outbreak in North Eastern 09.003 EV71 virus Kenya, 2011 P. Chua M. O. Obonyo, W. Arvelo, V. O. Ofula, Singapore (Singapore) A. Fidhow, B. Fields, R. Sang, E. Wurapa, 09.004 Ebola and Marburg viruses emergence K. Njenga, J. Montgomery at the human-animal interface Nairobi (Kenya) P. Formenty08.008 Evaluation of innate immune response in Geneva (Switzerland) acute and fulminant hepatitis E M. Majumdar, R. Ratho, Y. Chawla, M. P. Singh Chandigarh (India) Session 10 Vectorborne Diseases in HumansCoffee Break and AnimalsGround Level 16:00–16:30 Co-Chairs: Arnon Shimshony, Israeland Upper Level Saturday, February 16, 2013 Norbert Nowotny, Oman Room: Klimt Ballroom 2&3 16:30–18:00 SATURDAY Upper Level Saturday, February 16, 2013Session 09 10.001 A novel orthobunyavirus inEmerging Disease Mysteries European livestock: the emergenceCo-Chairs: Joseph Wamala, Uganda of Schmallenberg virus • February 16, 2013 Leo Liu, USA M. BeerRoom: Park Congress 16:30–18:00 Greifswald-Insel Riems (Germany)Ground Level Saturday, February 16, 2013 10.002 Emerging zoonotic vector-borne diseases in Europe09.001 Magnitude and distribution of Nodding N. Nowotny Syndrome in Northern Uganda Muscat (Oman) J. F. Wamala Kampala (Uganda) 10.003 Emerging insect vector-borne animal diseases in the eastern09.002 Nodding Syndrome: An emerging epilepsy Mediterranean disorder of sub-Saharan Africa E. Klement A. Winkler Rehovot (Israel) Munich (Germany) ProMED mail Program for Monitoring Emerging Diseases Subscribe for free email updates about threats to human, animal, and food plant health around the world. www.promedmail.org Sponsored by the International Society for Infectious Diseases ProMED Postcard 4 x 6 V6 V1.indd 1 5/19/11 11:22 AM 11 IMED 2013
  16. 16. S cientific Program SUNDAY • FEBRUARY 17, 2013 International Meeting on Emerging Diseases and Surveillance 2 013 Session 11 12.005 Characterizing zoonotic disease outbreaks in the United States Neglected Zoonotic Diseases H. Allen Co-Chairs: Matt Levison, USA McLean, VA (USA) Tam Garland, USA 12.006 Estimating global mortality associated with Room: Park Congress 08:30–10:30 the influenza A H1N1 pandemic in 2009: the Ground Level Sunday, February 17, 2013 WHO Global Pandemic Mortality Assessment (GLaMOR) project 11.001 The economic and health burden of neglected L. Simonsen1, P. Spreeuwenberg2, R. Lustig3, zoonotic diseases R. J. Talyor3, D. M. Fleming4, M. Kroneman2, P.Torgerson L. W. Kim3, M. D. Van Kerkhove 5, A. W. Mounts6, Zurich (Switzerland) J. W. Paget2 11.002 Rabies: the path to elimination 1 Washington DC, DC (USA), A. L. Willingham 2 Utrecht (Netherlands), 3Bethesda, DC (USA), Geneva (Switzerland) 4 Birmingham (United Kingdom), 5London 11.003 Echinococcosis: endemic and re-emergent (United Kingdom), 6Geneva (Switzerland) P. Craig 12.007 Domestic birds as surveillance systems for Salford (United Kingdom) monitoring West Nile virus lineage 2 enzootic 11.004 Implementing the roadmap to combat circulation: three years of experience in Greece Cysticercosis C. I. Dovas1, S. C. Chaintoutis1, A. L. Willingham A. Chaskopoulou1, S. Gewehr1, Geneva (Switzerland) M. Papanastassopoulou1, S. Mourelatos1, S. Zientara2, S. Lecollinet2, K. Danis3, T. Panagiotopoulos3 Session 12 1 Thessaloniki (Greece), 2Maisons-Alfort (France), Oral Presentations 3 Athens (Greece) 12.008 Weekly monitoring of human cases of West Nile Infection, Detection, and Protection: fever: an efficient way to assess the evolution of Adventures in Epidemiology the disease in Europe Co-Chairs: Philip Polgreen, USA L. Marrama Rakotoarivony, C. Bogaardt,February 17, 2013 Tom Yuill, USA E. Robinson, V. Estevez, J. Jansa, H. Zeller, D. Coulombier Room: Klimt Ballroom 2&3 8:30–10:30 Stockholm (Sweden) Upper Level Sunday, February 17, 2013 12.009 Determinants of active participation in internet- 12.001 Evaluation of cholera and other diarrheal diseases based surveillance systems surveillance system, Niger State, Nigeria, 2012 D. Paolotti, P. Bajardi •SUNDAY A.T. Bashorun1, A. Ahumibe1, S. Olugbon1, Turin (Italy) A. Taju1, P. Nguku1, K. Sabitu2 12.010 An investigation of Salmonella enteritidis PT1 1 Abuja (Nigeria), 2Zaria (Nigeria) cases linked to consumption of a pasteurized 12.002 Surveillance during Hajj: Patterns and causes of liquid egg white product in England and mortality amongst Indonesian pilgrims Wales, 2012 M. Pane1, S. Imari1, N. Kandun1, G. Samaan2 O. Esan, C. Lane, T. Peters 1 Jakarta (Indonesia), 2Canberra, ACT (Australia) London (United Kingdom) 12.003 ECDC/EpiNorth epidemic intelligence activities 12.011 Effects of climate change on the distribution of during EURO 2012 in Poland and Ukraine bluetongue and epizootichaemorrhagic disease A. M. Gherasim1, I. Linina2, G. Rimseliene3, vector in Southern Alberta (Canada) and L. Paine Hallström1, J. Mantero1, P. Penttinen4 Montana(USA) 1 Stockholm (Sweden), 2Brussels (Belgium), A. Zuliani1, A. Massolo1, S. Marshall1, T. J. Lysyk2, 3 Oslo (Norway), 4Stockhokm (Sweden) G. Johnson3, S. Cork1 12.004 Improving capacity to investigate and respond to 1 Calgary, AB (Canada), 2Lethbridge, AB (Canada), emerging infectious disease outbreaks in East and 3 Bozeman, MT (USA) Central Africa H. M. Amuguni1, T. Odoch2, R. Nauma2 1 North Grafton, MA (USA), 2Kampala (Uganda) 12 IMED 2013
  17. 17. S cientific Program SUNDAY • FEBRUARY 17, 2013 International Meeting on Emerging Diseases and Surveillance 2 013Coffee Break Session 15 Ground Level 10:30–11:00 Panel Discussionand Upper Level Sunday, February 17, 2013 Updates from ProMED Co-Chairs: Stephen Morse, USA Eskild Petersen, DenmarkSession 13 Plenar y Lecture Room: Klimt Ballroom 2&3 14:30–16:00 Upper Level Sunday, February 17, 2013Global Approach to the Control of IntroductionFoot and Mouth Disease L. MadoffChair: Jacques Acar, France Boston, MA (USA)Room: Park Congress 11:00–11:45 15.001 Novel coronavirus in the Eastern MediterraneanGround Level Sunday, February 17, 2013 M. Pollack New York, NY (USA)13.001 Global approach to the control of foot and mouth disease 15.002 Continuing global emergence of dengue B.Vallat S. Chotivichien1, Q. Nguyen1, J.Torres3 Paris (France) 1 Bangkok (Thailand), 2Hanoi (Vietnam). 3Caracas (Venezuela). 15.003 Fungal meningitis outbreakPoster Presentations II (Session 22) L. Lutwick New York, NY (USA)Sunday, February 17, 2013 11:45–13:15 15.004 Yellow fever in Darfur, SudanBruckner/Mahler/Brahms - Upper Level J. Woodall1, T.Yuill2and Klimt Ballroom - Upper Level 1 Rio de Janeiro (Brazil), 2Mapleton, UT (USA)Sessions 22.001–22.185 (see pages 127–190) Coffee BreakSession 14 SUNDAY Ground Level 16:00–16:30Cutting Edge Diagnostics for the and Upper Level Sunday, February 17, 2013Detection of Novel and NeglectedDiseases • Session 16 February 17, 2013Co-Chairs: Giuseppe Cornaglia, Italy Keith Klugman, USA Disease Surveillance Co-Chairs: John Brownstein, USARoom: Park Congress 14:30–16:00 Ann Marie Kimball, USAGround Level Sunday, February 17, 2013 Room: Park Congress 16:30–18:0014.001 MALDI-TOF MS beyond bacterial and fungal Ground Level Sunday, February 17, 2013 identification J.Vila 16.001 Integrating data mining and crowd-sourcing for Barcelona (Spain) disease surveillance14.002 Next generation sequencing in clinical J. Brownstein microbiology diagnosis, what have we Boston, MA (USA) achieved so far? 16.002 Participatory epidemiology:putting the public in J.Van Eldere public health surveillance Louvain (Belgium) M. Smolinski14.003 Detection of emerging antimicrobial threats in San Francisco, CA (USA) developing countries 16.003 Towards synergy between surveillance systems K. Klugman for Epidemic Intelligence. Atlanta, GA (USA) L.Vaillant Saint Maurice (France)Co-sponsored by ESCMID 13 IMED 2013
  18. 18. S cientific Program SUNDAY • FEBRUARY 17, 2013 International Meeting on Emerging Diseases and Surveillance 2 013 Session 17 17.006 Spotted fever group Rickettsia species and Anaplasma phagocytophilum in lizards Oral Presentations ticks, Algeria Hot Topics H. Soualah-Alila1, Z. Bouslama2 1 Annaba, AL-AN (Algeria), 2Annaba (Algeria) Co-Chairs: Daniel Beltrán-Alcrudo, Italy Larry Lutwick, USA 17.007 Sequelae of human Cryptosporidiosis in patients living in Östersund during a large Room: Klimt Ballroom 2&3 16:30–18:00 waterborne outbreak Upper Level Sunday, February 17, 2013 J. Lindh1, A. Wallensten1, J. Bergstrom1, 17.001 Anthrax pleural effusions and drainage M. Lilja2, M. Widerstrom2 1979–2011: A Russia-USA partnership study. 1 Solna (Sweden), 2Östersund (Sweden) D. Lucey1, L. Grinberg2, F. Abramova2 17.008 Evolution of gonococcal strain 1 Washington, DC (USA), 2Yekaterinburg (Russian susceptibility to antibiotics in France: Federation) data from a national sentinel surveillance 17.002 Schmallenberg virus—Harmonized European network, 2001–2012 data collection for an emerging disease G. La Ruche1, P. Sednaoui2, B. Bercot2, A. Afonso1, F. Berthe1, K. Willgert2, D. Verloo1, E. Cambau2, A. Goubard2 J. Cortinas Abrahantes1, A. Bau1, J. Richardson1 1 Saint-Maurice (France), 2Paris (France) 1 Parma (Italy), 2London (United Kingdom) 17.003 No evidence for zoonotic transmission of Schmallenberg virus in areas with veterinary activity C. Reusken1, C. van den Wijngaard1, M. Beer2, R. Bouwstra3, H. van den Kerkhof1, W. van der Poel3, J. Schmidt-Chanasit4, P. Vellema5, I. Wouters6, M. Koopmans7 1 Bilthoven (Netherlands), 2Greifswald-Insel Riems (Germany), 3Lelystad (Netherlands), 4Hamburg (Germany), 5Deventer (Netherlands), 6UtrechtFebruary 17, 2013 (Netherlands), 7Rotterdam (Netherlands) 17.004 The interaction of the spike glycoproteins of bat-borne SARS-like-CoVs with chiropteran cells during the entry process M. Hoffmann, N. Krüger Hanover (Germany) •SUNDAY 17.005 Tick species and tick-borne viruses of Eastern cancelled and North Eastern parts of Kenya: Health risk implications among pastoral communities J. Mutisya1, J. Lutomiah1, L. Musila1, S. Khamadi1, H. Koka1, E. Chepkorir1, A. Makio1, J. Bast2, E. Wurapa1, R. Sang1 Mayor’s Reception 1 Nairobi (Kenya), 2Kisumu (Kenya) Sunday, February 17, 2013 20:00–22:00 Vienna City Hall (Entrance: Lichtenfelsgasse) - no transportation provided 14 IMED 2013
  19. 19. S cientific Program MONDAY • FEBRUARY 18, 2013 International Meeting on Emerging Diseases and Surveillance 2 013Session 18 Coffee BreakEconomics of Emerging Ground Level 10:30–11:00Infectious Diseases and Upper Level Monday, February 18, 2013Co-Chairs: Nilufar Rakhmanova, USA David Fisman, Canada Session 20 Room: Park Congress 08:30–10:30Ground Level Monday, February 18, 2013 Plenar y Lecture18.001 Emerging infections and poverty: Big Data, Industry and Disease Lessons from the Americas Surveillance L. Ivers Chair: Larry Madoff, USA Boston, MA (USA) Room: Park Congress 11:00–11:4518.002 Vaccination choices and their impact on Ground Level Monday, February 18, 2013 immunization programmes P. Manfredi 20.001 Big data, industry and disease surveillance Pisa (Italy) A. Signorini18.003 Externalities, transaction costs and infectious Iowa City, IA (USA) diseases P. Polgreen Iowa City, IA (USA)18.004 Is it cost-effective? Best practices on evaluating the bang-for-the-buck in communicable disease control D. Fisman Toronto (Canada)Session 19 Diseases Without BordersCo-Chairs: Adriano Duse, South Africa Benson Estambale, KenyaRoom: Klimt Ballroom 2&3 08:30–10:30Upper Level Monday, February 18, 201319.001 Hepatitis E outbreak at a refugee camp J. Ahmed Nairobi (Kenya)19.002 Dynamics of the Uganda Ebola outbreak A. Duse Johannesburg (South Africa)19.003 From surveillance to prevention: developing MONDAY a risk assessment framework for “novel” emerging infections S. Morse • New York, NY, and Davis, CA (USA) February 18, 201319.004 NDM-1 and the international spread of antibiotic resistance M.Toleman Cardiff, (United Kingdom) 15 IMED 2013
  20. 20. Poster Presentations I SATURDAY • FEBRUARY 16, 2013 International Meeting on Emerging Diseases and Surveillance 2 013 Session 21 21.009 Are the neurological rehabilitation wards at higher risk for multi-drug resistant micro- Poster Presentations I organisms infections? A retrospective analysis Saturday, February 16, 2013 11:45–13:15 from a rehabilitation center in Northern Italy Bruckner/Mahler/Brahms • Upper Level focusing on clinical risk factors M. Riccò1, D. Nicolotti2, C. Signorelli1, P. Camia1, Antimicrobial Resistance S. Cattani1, V. Ciorba1, F. Pezzetti1, H. Cerrel Bazo2 1 Parma (Italy), 2Piacenza (Italy) 21.001 Ertapenem-resistance in Klebsiella pneumoniae isolates from Croatia 21.010 Successful management of nosocomial B. Bedenic1, M. Barisic1, Z. Bosnjak1, J. Vranes1, ventriculitis and meningitis caused by extensive V. Plecko1, D. Varda-Brkic1, S. Sardelic2 drug resistant Acinetobacter baumannii, Austria 1 Zagreb (Croatia), 2Split (Croatia) M. Drescher, M. Hoenigl, G. Feierl, T. Valentin, K. Seeber, E. Leitner, G. Zarfel, W. Duettmann, 21.002 Importance of clonal properties in addition R. Krause, A. J. Grisold to antibiotic consumption in determining the Graz (Austria) differences between macrolide resistant and susceptible Streptococcus pyogenes 21.011 Antimicrobial resistance of human Salmonella serovar Typhimurium U302 strains in Slovakia:February 16, 2013 C. Silva-Costa, A. Friães, M. Ramirez, J. Melo-Cristino, P. Portuguese Group for prevalence of R-type ASSuT the Study of Streptococcal Infections L. Majtanova, V. Majtan Lisbon (Portugal) Bratislava (Slovakia) 21.003 Carbapenem resistance of Pseudomonas 21.012 Inducuble clindamycin resistance in methicillin- aeruginosa and Acinetobacter baumannii strains susceptible and methicillin-resistant Staphylococcus • in the intensive care unit in Romania aureus of inpatient, outpatient and healthySATURDAY S. L. Pandrea, L. Matros, M. I. Ciontea carriers Cluj (Romania), S. Uzunovi1, A. Ibrahimagi1, F. Kamberovi2, M. Kunarac1, M. I. A. Rijnders3, E. E. Stobberingh3 21.004 Antibiotic resistance of Pseudomonas aeruginosa 1 Zenica (Bosnia and Herzegovina), 2Ljubljana strains isolated from nosocomial infections in (Slovenia), 3Mastricht (Netherlands) Romania S. L. Pandrea, L. Matros, M. I. Ciontea 21.013 Serotype and clindamycin-resistance of Cluj (Romania) Streptococcus suis in diseased pigs and humans in upper northeast Thailand 21.005 Antimicrobial resistance of gram-negative bacilli S. Angkititrakul1, T. C. Nutravong2 causing infections in intensive care units in 1 Khon Kaen (Thailand), 2Khon Kaen, (Thailand) Makkah hospitals, Saudi Arabia A. Asghar 21.014 Escherichia coli B2 and D virulent phylotypes Makkah (Saudi Arabia) carry extended-spectrum and pAmpC betalactamases in healthy dogs with no 21.006 Inhibitory effects of Lactobacillus plantarum antimicrobial pressure and Lactobacillus rahmnosus on the growth of A. Belas, N. Couto, C. Pomba Pseudomonas aeruginosa Lisbon (Portugal) S. Aminnezhad, K. Kermanshahi, R. Ranjbar, O. Baghery 21.015 Antimicrobial resistance of Salmonella stanley Tehran (Iran, Islamic Republic of) isolated from pigs, dogs and humans in northeast of Thailand 21.007 Infection due to colistin-resistant Enterobacteriacae: A. Polpakdee, S. Angkititrakul A single tertiary centre experience in critically ill Khon Kaen (Thailand) patients from Saudi Arabia M. A. Garbati1, A. Bin Abdulhak2, A. I. AlGodair3, 21.016 Analysis of the plasmid profile in Salmonella H. Sakkijha1 typhimurium strains isolated in the Republic of 1 Riyadh, Riyadh (Saudi Arabia), 2Kansas City, MO Uzbekistan (USA) L.Tuychiev, G. Abdukhalilova, A. Ibragimov, I. Akhmedov 21.008 Infection with Escherichia coli and antimicrobial Tashkent (Uzbekistan) susceptibility I. Zurak 21.017 Characterization of uropathogenic E. coli and Zagreb (Croatia) detection their ESBL TEM and SHV genes S. N. El-Sukhon Irbid (Jordan) 16 IMED 2013

×